dc.contributor.author | Yılmaz, Sarper | |
dc.contributor.author | Ertin, Hakan | |
dc.contributor.author | Elaldı, Nazif | |
dc.date.accessioned | 2021-03-02T19:17:17Z | |
dc.date.available | 2021-03-02T19:17:17Z | |
dc.date.issued | 2020 | |
dc.identifier.citation | Yılmaz S., Elaldı N., Ertin H., " An Ongoing Debate: Are the Patients Receiving Angiotensin-Converting Enzyme Inhibitors and/or Angiotensin Receptor Blockers More Susceptible to COVID-19?", Anadolu Kliniği Tıp Bilimleri Dergisi, cilt.25, sa.1, ss.79-84, 2020 | |
dc.identifier.other | vv_1032021 | |
dc.identifier.other | av_48ebd1b0-bf4f-46ad-a4d7-8f4468b5ecc5 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/5554 | |
dc.identifier.uri | https://doi.org/10.21673/anadoluklin.716125 | |
dc.language.iso | eng | |
dc.subject | Klinik Tıp (MED) | |
dc.subject | Sağlık Bilimleri | |
dc.title | An Ongoing Debate: Are the Patients Receiving Angiotensin-Converting Enzyme Inhibitors and/or Angiotensin Receptor Blockers More Susceptible to COVID-19? | |
dc.type | Makale | |
dc.relation.journal | Anadolu Kliniği Tıp Bilimleri Dergisi | |
dc.contributor.department | , , | |
dc.identifier.volume | 25 | |
dc.identifier.issue | 1 | |
dc.identifier.startpage | 79 | |
dc.identifier.endpage | 84 | |
dc.contributor.firstauthorID | 2197976 | |